The Company is committed to expanding and accelerating vaccine supply to the African region through 2022 and beyond to help governments reach their vaccination targets... Read More
AstraZeneca COVID-19 vaccine
Positive results from a preliminary analysis of an ongoing safety and immunogenicity trial (D7220C00001) showed that AstraZeneca COVID-19 vaccine (ChAdOx1-S [Recombinant]), when given as a... Read More